Edwards SAPIEN 3 Transcatheter Heart Valve (9600TFX)
Edwards Lifesciences, LLC · Decision date Oct 28, 2026
What did the FDA decide?
Edwards Lifesciences, LLC filed PMA supplement P200015/S084 for the SAPIEN 3 Transcatheter Heart Valve (9600TFX), a percutaneously delivered pulmonary valve prosthesis under product code NPV. The FDA record lists it as a 30-Day Notice with decision OK30, dated 2026-10-28. The supplement reason field cites a process change involving manufacturer, sterilizer, packager, or supplier, and the statement describes implementing an alternative supplier of a chemical manufacturing aid.
The supplement number ties this action to PMA P200015, but it is a notice about a supplier change, not an original approval of the valve system. The fields do not name the chemical manufacturing aid, the prior or replacement supplier, the affected manufacturing step, or any supporting data. The reported purpose does not by itself establish safety or clinical effectiveness, and no clinical or regulatory conclusion beyond this descriptive record is supported.
The available source does not specify which category—manufacturer, sterilizer, packager, or supplier—applies, nor identify the device component affected. Researchers should treat the stated purpose as the applicant's notice content rather than corroborated evidence of device performance.
FDA approval order statement
implementing an alternative supplier of a chemical manufacturing aid
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 28, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P200015/S084
- Regulatory pathway
- PMA supplement
- Applicant
- Edwards Lifesciences, LLC
- Product code
- NPV
- Decision code
- OK30
- Decision date
- Oct 28, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Pulmonary valve prosthesis percutaneously delivered.
- Applicant
- Edwards Lifesciences, LLC
- Product code
- NPV
- FDA device class
- f
For the original device and its historical approval scope, see PMA P200015. Subsequent supplements may change the device or its indications.
FDA decision timeline
P200015 · Original PMA
Edwards SAPIEN 3 Transcatheter Heart Valve System with Edwards Commander Delivery System
P200015/S083 · Related supplement
Edwards Crimper (9600LDS20, 9600LDS23, 9600LDS26, 9600LDS29)
P200015/S084 received
Application receipt date recorded by FDA.
P200015/S077 · Related supplement
SAPIEN 3 Transcatheter Pulmonary Valve System with Alterra C Adaptive Prestent
P200015/S084 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P200015. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P200015
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Edwards Lifesciences, LLC | PMA approval | Aug 31, 2020 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Sep 23, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 27, 2026 | FDA |
Explore the linked device profile
Other records with product code NPV
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Harmony TPV SystemP200046/S052 | Medtronic, Inc. | PMA supplement | Sep 30, 2026 | FDA |
Harmony TPV SystemP200046 | Medtronic, Inc. | PMA approval | Mar 26, 2021 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Edwards Lifesciences, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- One Edwards Way, Irvine, CA, 92614
Sources and methodology
- Original FDA record: P200015/S084
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


